Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
222.34
324.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Shenzhen Mindray Bio-Medical Electronics Co Ltd
Shenzhen Mindray Bio-Medical Electronics Co Ltd
Cash from Operating Activities
Shenzhen Mindray Bio-Medical Electronics Co Ltd
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Cash from Operating Activities
¥14.4B
|
CAGR 3-Years
17%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Cash from Operating Activities
¥689.1m
|
CAGR 3-Years
67%
|
CAGR 5-Years
106%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Cash from Operating Activities
¥1.8B
|
CAGR 3-Years
9%
|
CAGR 5-Years
26%
|
CAGR 10-Years
28%
|
|
|
J
|
Jafron Biomedical Co Ltd
SZSE:300529
|
Cash from Operating Activities
¥1.2B
|
CAGR 3-Years
2%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
L
|
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
|
Cash from Operating Activities
¥809.6m
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
11%
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Cash from Operating Activities
¥132.5m
|
CAGR 3-Years
-66%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
Glance View
Shenzhen Mindray Bio-Medical Electronics Co., Ltd., founded in 1991, has evolved into a leading global player in the medical device industry, with a compelling story of innovation and resilience at its core. Originating from the bustling tech hub of Shenzhen, the company specializes in developing and manufacturing high-quality medical equipment and solutions, particularly in the fields of imaging, in-vitro diagnostics, and patient monitoring. Mindray's commitment to advanced research and development has led it to achieve a strong competitive edge, enabling it to penetrate international markets and establish partnerships with healthcare providers across over 190 countries. With an unwavering focus on improving healthcare outcomes, Mindray is positioned not just as a manufacturer, but as a trusted partner in enhancing patient care worldwide. As an investor, you would be interested to know that Mindray's growth trajectory has been remarkable, characterized by steady revenue increases and robust profitability. The company's diversified product portfolio, including vital sign monitors, ultrasound systems, and laboratory solutions, addresses a wide array of healthcare needs, making it resilient to market fluctuations. Moreover, in response to the growing global emphasis on healthcare quality, Mindray continuously expands its innovations, investing significantly in R&D and leveraging advanced technologies like artificial intelligence. With a strong balance sheet and a commitment to ethical business practices, Mindray not only seeks to drive strong financial performance but also aims to foster a sustainable impact on global health, making it an attractive prospect for forward-thinking investors aiming to align their portfolios with socially responsible investments.
See Also
What is Shenzhen Mindray Bio-Medical Electronics Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
14.4B
CNY
Based on the financial report for Sep 30, 2024, Shenzhen Mindray Bio-Medical Electronics Co Ltd's Cash from Operating Activities amounts to 14.4B CNY.
What is Shenzhen Mindray Bio-Medical Electronics Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
24%
Over the last year, the Cash from Operating Activities growth was 9%. The average annual Cash from Operating Activities growth rates for Shenzhen Mindray Bio-Medical Electronics Co Ltd have been 17% over the past three years , 24% over the past five years .
You don't have any saved screeners yet
